Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

81.60 +0.23 (+0.28%)
Official Closing Price Updated: 7:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Here's How Much $100 Invested In Boston Scientific 15 Years Ago Would Be Worth Today
Via Benzinga
Jim Cramer Says 'Entertainment Stocks Are So Hated': Here's One That's 'Not Expensive Anymore'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Devon Energy Corporation’s (NYSE: DVN) stock is "low enough, it had a bad quarter, it’s being punished 
Via Benzinga
Good technical signals and a possible breakout for BOSTON SCIENTIFIC CORP.
NYSE:BSX Shows Potential for a Breakout. 
Via Chartmill
Stock Market Falls Into Correction On Hawkish Fed: Weekly Review
Treasury yields surged to long-term highs, while leading stocks buckled. 
Via Investor's Business Daily
Zoom Video, eBay And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by around 275 points on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
The Latest Analyst Ratings for Boston Scientific
Via Benzinga
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Via Benzinga
Boston Scientific's 'Next Level' Long-Term Plans: Why 2 Analysts Boost Price Targets
Boston Scientific Corporation (NYSE: BSX) CEO Mike Mahoney set the theme at the company's 2023 Investor Day  
Via Benzinga
CrowdStrike Holdings To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Thursday
Needham increased the price target for CrowdStrike Holdings, Inc. (NASDAQ: CRWD) from $200 to $215. Needham analyst Alex Henderson maintained a Buy rating. CrowdStrike shares fell 1% to close at... 
Via Benzinga
Boston Scientific Briefly Launches Into Buy Zone, But Investor Day Hype Cools
The company is following up on acquisition plans announced Tuesday with its Investor Day. 
Via Investor's Business Daily
Price Over Earnings Overview: Boston Scientific
Via Benzinga
A Look Into Boston Scientific Inc's Price Over Earnings
Via Benzinga
The 3 Most Promising Healthcare Stocks to Own Now
These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products. 
Via InvestorPlace
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today
Via Benzinga
Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains
The demand for healthcare devices and tools are increasing which means their stocks will provide profits for investors. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Boston Scientific Jumps On Positive Surprise On Farapulse For AFIB Ablation
Signal(s) to enter, add, reduce, exit, hold or change. 
Via Benzinga
Jabil, Boston Scientific, Hersha Hospitality Trust And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Analyst Expectations for Boston Scientific's Future
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
Via Benzinga
How Is The Market Feeling About Boston Scientific?
Via Benzinga
Boston Scientific Surges As It Looks To Enter A Market Worth Nearly $8 Billion
The company tested a new means of treating abnormal heartbeats. 
Via Investor's Business Daily
German Pharma Firm Bayer's New Parkinson's Treatment Shows Promise: What the Phase 1 Trial Reveals
Boston Scientific Corporation (NYSE: BSX) released 12-month results from the pivotal ADVENT trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields... 
Via Benzinga
Why Is Boston Scientific Stock Trading Higher Today?
Boston Scientific Corporation (NYSE: BSX) released 12-month results from the pivotal ADVENT trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields... 
Via Benzinga
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year. 
Via Investor's Business Daily
Target, Pinterest And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval
Boston Scientific Corp (NYSE: BSX) will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation (PFA) system at the 2023 European Society of Cardiology Congress on 27 August.... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.